ExodusPoint Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-246,865
| Closed | -$1.48M | – | 1335 |
|
|
2024
Q4 | $1.48M | Buy |
+246,865
| New | +$1.48M | 0.01% | 752 |
|
|
2024
Q1 | – | Sell |
-763,885
| Closed | -$3.74M | – | 1326 |
|
|
2023
Q4 | $3.74M | Sell |
763,885
-111,190
| -13% | -$545K | 0.02% | 367 |
|
|
2023
Q3 | $4.77M | Buy |
875,075
+734,803
| +524% | +$4M | 0.05% | 356 |
|
|
2023
Q2 | $941K | Buy |
140,272
+112,068
| +397% | +$752K | 0.01% | 1036 |
|
|
2023
Q1 | $249K | Sell |
28,204
-62,813
| -69% | -$555K | ﹤0.01% | 1422 |
|
|
2022
Q4 | $695K | Sell |
91,017
-254,547
| -74% | -$1.94M | 0.01% | 1043 |
|
|
2022
Q3 | $2.46M | Buy |
345,564
+308,252
| +826% | +$2.19M | 0.03% | 667 |
|
|
2022
Q2 | $302K | Sell |
37,312
-169,454
| -82% | -$1.37M | ﹤0.01% | 1485 |
|
|
2022
Q1 | $2.87M | Buy |
206,766
+193,889
| +1,506% | +$2.69M | 0.04% | 558 |
|
|
2021
Q4 | $361K | Buy |
+12,877
| New | +$361K | ﹤0.01% | 1544 |
|
|
2021
Q1 | – | Sell |
-10,843
| Closed | -$641K | – | 2020 |
|
|
2020
Q4 | $641K | Sell |
10,843
-1,271
| -10% | -$75.1K | 0.01% | 1035 |
|
|
2020
Q3 | $589K | Sell |
12,114
-72,402
| -86% | -$3.52M | 0.01% | 874 |
|
|
2020
Q2 | $4.09M | Buy |
+84,516
| New | +$4.09M | 0.11% | 189 |
|
|
2019
Q4 | – | Sell |
-11,908
| Closed | -$368K | – | 1434 |
|
|
2019
Q3 | $368K | Sell |
11,908
-70,225
| -86% | -$2.17M | 0.01% | 766 |
|
|
2019
Q2 | $3.97M | Buy |
+82,133
| New | +$3.97M | 0.16% | 75 |
|